πŸ‡ΊπŸ‡Έ FDA
Patent

US 7169779

Inhibitors of p38

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7169779 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/16, A61P1/18